XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Stock-Based Compensation  
Schedule of stock based compensation expense categories in statement of operations

Three months ended March 31, 

    

2024

    

2023

Sales and marketing

$

373

$

401

General and administrative

573

 

554

Research and development

 

156

 

173

Total stock‑based compensation

$

1,102

$

1,128

Schedule of stock option activity

Weighted

average

Weighted

remaining

Number of

average exercise

contractual term

    

shares

    

price per share

    

(years)

Outstanding at January 1, 2024

 

2,162,453

$

11.48

 

  

Granted

 

219,600

 

7.07

 

  

Exercised

 

(37,219)

 

5.92

 

  

Canceled/forfeited

 

(63,521)

 

12.69

 

  

Outstanding at March 31, 2024

 

2,281,313

$

11.11

 

6.60

Vested and expected to vest at March 31, 2024

 

2,235,434

$

11.15

 

6.55

Exercisable at March 31, 2024

 

1,606,505

$

11.58

 

5.70

Schedule of weighted average assumptions

Three months ended

    

March 31, 2024

Expected dividend yield

 

Expected volatility

 

72.9

%

Risk‑free interest rate

 

4.28

%

Expected term (in years)

 

6.25

Schedule of restricted stock units (RSUs)

Number of

    

shares

Outstanding at January 1, 2024

907,203

Granted

333,800

Vested

(141,014)

Canceled/forfeited

(20,848)

Outstanding at March 31, 2024

1,079,141